BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$323M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$345M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$305M |
| 4 |
PPLI
People Inc
PPLI
|
+$203M |
| 5 |
Visa
V
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.89% |
| 2 | Consumer Discretionary | 7.29% |
| 3 | Healthcare | 5.23% |
| 4 | Financials | 5.21% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUTH
3026
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $92.2K | ﹤0.01% |
8,337
+6,511
| +357% | +$58.8K |
|
3027
Phibro Animal Health
PAHC
$1.38B
| $92.2K | ﹤0.01% |
5,298
+3,596
| +211% | +$76.7K |
|
|
ECOM
3028
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $92K | ﹤0.01% |
6,358
+5,377
| +548% | +$89.2K |
|
3029
Barrett Business Services
BBSI
$800M
| $92K | ﹤0.01% |
7,016
+5,904
| +531% | +$80.8K |
|
3030
AdvanSix
ASIX
$446M
| $91.8K | ﹤0.01% |
7,125
+5,447
| +325% | +$68K |
|
3031
Caleres
CAL
$461M
| $91.7K | ﹤0.01% |
9,595
-96,788
| -91% | -$778K |
|
|
TWOU
3032
DELISTED
2U Inc
TWOU
| $91.6K | ﹤0.01% |
90
-1
| -1% | -$1.19K |
|
|
HTBK
3033
DELISTED
Heritage Commerce
HTBK
| $91.4K | ﹤0.01% |
13,739
+11,305
| +464% | +$77.9K |
|
3034
Bank First Corp
BFC
$1.76B
| $91.3K | ﹤0.01% |
1,555
+1,167
| +301% | +$72.8K |
|
|
NPTN
3035
DELISTED
NEOPHOTONICS CORP
NPTN
| $90.8K | ﹤0.01% |
14,905
+10,653
| +251% | +$81.3K |
|
3036
Sterling Infrastructure
STRL
$16.9B
| $90.6K | ﹤0.01% |
6,395
+5,411
| +550% | +$68K |
|
3037
Forrester Research
FORR
$224M
| $89.9K | ﹤0.01% |
2,743
+1,868
| +213% | +$63.9K |
|
|
SYRS
3038
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $89.9K | ﹤0.01% |
1,017
+704
| +225% | +$80K |
|
3039
Plains All American Pipeline
PAA
$16.5B
| $89.9K | ﹤0.01% |
15,034
+5,198
| +53% | +$38.8K |
|
|
VRAY
3040
DELISTED
ViewRay, Inc.
VRAY
| $89.6K | ﹤0.01% |
25,614
+21,280
| +491% | +$59.2K |
|
3041
Oceaneering
OII
$5.11B
| $89.5K | ﹤0.01% |
25,422
+16,865
| +197% | +$89K |
|
3042
Viking Therapeutics
VKTX
$3.84B
| $89.3K | ﹤0.01% |
15,339
+5,740
| +60% | +$39.5K |
|
|
CLDT
3043
Chatham Lodging
CLDT
$601M
| $88.9K | ﹤0.01% |
11,663
+6,980
| +149% | +$45.8K |
|
|
MTL
3044
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $88.8K | ﹤0.01% |
58,802
+45,160
| +331% | +$76.3K |
|
3045
Liberty Latin America Class A
LILA
$1.67B
| $88.7K | ﹤0.01% |
15,830
+11,971
| +310% | +$72.9K |
|
3046
i3 Verticals
IIIV
$325M
| $88.6K | ﹤0.01% |
3,507
+2,788
| +388% | +$74.7K |
|
3047
UroGen Pharma
URGN
$2.34B
| $88.5K | ﹤0.01% |
4,588
+3,521
| +330% | +$79.7K |
|
3048
Bank of Marin Bancorp
BMRC
$462M
| $88.5K | ﹤0.01% |
3,056
+2,565
| +522% | +$80.7K |
|
3049
First Mid Bancshares
FMBH
$1.39B
| $88.5K | ﹤0.01% |
3,547
+2,838
| +400% | +$71.8K |
|
3050
Comtech Telecommunications
CMTL
$52.7M
| $88.4K | ﹤0.01% |
6,315
+4,887
| +342% | +$78.1K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2020 Portfolio in Review
As of Q3 2020, BNP Paribas Financial Markets held 4,385 positions worth $69.9B, up 23% from $56.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $2.99B of net new capital in Q3 2020, opening 85 new positions and adding to 2,667 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $345M trimmed.
- BNP Paribas Financial Markets's largest Q3 2020 buy was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q3 2020, an estimated $1.93B increase.
- BNP Paribas Financial Markets's biggest Q3 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $345M.
- BNP Paribas Financial Markets fully exited People Inc in Q3 2020, selling an estimated $203M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $69.9B portfolio in Q3 2020.
- BNP Paribas Financial Markets opened 85 new positions and closed 175 in Q3 2020.
- BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $69.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.